ACMIT continues to FP2
The Austrian Center for Medical Innovation and Technology (ACMIT - see our previous post) has just passed its 4-year evaluation by FFG and has been granted to continue the various R&D activities for another 3 years as a Comet K-1 center. ACMIT works in the domain of Minimally Invasive Procedures together with its renown partners such as HTWK, Queens or JHU. Stay tuned for more results coming in
Comments